How many institutional investors hold CNXC?

4 tracked institutional investors disclosed a position in CNXC (CONCENTRIX CORP) in their most recent 13F filing.

Who is the largest institutional holder of CNXC?

Ken Griffin, Citadel Advisors, holds the largest disclosed position in CNXC, valued at $64M.

Where does this CNXC ownership data come from?

SEC Form 13F-HR filings, accessed via EDGAR. 13F filings are disclosed quarterly with a 45-day reporting delay and cover U.S.-listed long equity positions only. This is not investment advice.

CNXC — CONCENTRIX CORP

Name: CONCENTRIX CORP (CNXC) — Institutional Ownership
Creator: InvestorLens
License: https://www.sec.gov/about/website-policies

Public company

For educational research only.InvestorLens analyzes public regulatory filings (SEC EDGAR, STOCK Act PTRs) that may be delayed by 45 days or more. Information shown is historical and is not financial, legal, or tax advice, nor a recommendation or solicitation to buy or sell any security. Always do your own research.

InvestorLens aggregates public filing data to show which tracked investors reported holdings in this stock. Dollar values represent reported position values, not market capitalization, and may be delayed up to 45 days. Not a recommendation.

Sourced from SEC EDGAR public filings

About CONCENTRIX CORP (CNXC)

CONCENTRIX CORP (CNXC) appears in the most recent 13F filings of 4 tracked institutional investors. The largest disclosed position is held by Ken Griffin (Citadel Advisors), valued at $64M. Across recent filings, tracked investors recorded 3 new positions, 0 increased, 1 reduced, and 1 exited. All data sourced from SEC 13F filings.

Smart Money Consensus™

Based on recent institutional activity in CNXC

/100

Institutional Accumulation

Added / Increased3

Reduced1

Exited1

BearishBullish

Crowded Trade Score™

How many top investors track CNXC

/100

Emerging Interest

4investors

A small number of top investors own this.

UndiscoveredCrowded

151015+

CNXC Ownership Composition

How CONCENTRIX CORP is held across tracked investor types, based on reported 13F positions.

Dominant Type

Other

99% of tracked value

Institutions

tracked investors

Total Reported

$80.1M

combined 13F value

Other98.8%
Hedge Funds1.2%

Other(3)

98.8%

Hedge Funds(1)

1.2%

Tracked investors reporting CNXC

Investor	Firm	Shares	Market value	% of portfolio	As of
Ken Griffin	Citadel Advisors	2.3M	$63.6M	0.01%	Mar 31, 2026
Izzy Englander	Millennium Management	347K	$9.5M	0.00%	Mar 31, 2026
Ray Dalio	Bridgewater Associates	145.8K	$6.1M	0.08%	Dec 31, 2025
Steve Cohen	Point72 Asset Management	34.2K	$935.7K	0.00%	Mar 31, 2026

Ken GriffinMar 31, 2026
Citadel Advisors
Shares
2.3M
Value
$63.6M
% Portfolio
0.01%
Izzy EnglanderMar 31, 2026
Millennium Management
Shares
347K
Value
$9.5M
% Portfolio
0.00%
Ray DalioDec 31, 2025
Bridgewater Associates
Shares
145.8K
Value
$6.1M
% Portfolio
0.08%
Steve CohenMar 31, 2026
Point72 Asset Management
Shares
34.2K
Value
$935.7K
% Portfolio
0.00%

Recent activity

Investor	Action	Δ %	Current value	Filing date
Steve Cohen	New	—	$1.4M	Feb 17, 2026
Steve Cohen	New	—	$935.7K	May 15, 2026
Ray Dalio	Sold	-100.00%	$0	May 15, 2026
Ray Dalio	Reduced	-11.28%	$6.1M	Feb 13, 2026
Ray Dalio	New	—	$7.6M	Nov 13, 2025

Steve Cohen
New
$1.4MFeb 17, 2026
Steve Cohen
New
$935.7KMay 15, 2026
Ray Dalio
Sold
$0(-100.00%)May 15, 2026
Ray Dalio
Reduced
$6.1M(-11.28%)Feb 13, 2026
Ray Dalio
New
$7.6MNov 13, 2025

Frequently asked questions

How many institutional investors hold CNXC?: 4 tracked institutional investors disclosed a position in CNXC (CONCENTRIX CORP) in their most recent 13F filing.
Who is the largest institutional holder of CNXC?: Ken Griffin, Citadel Advisors, holds the largest disclosed position in CNXC, valued at $64M.
Did institutional ownership of CNXC increase or decrease?: Across recent 13F filings, tracked investors recorded 3 new positions, 0 increased, 1 reduced, and 1 fully exited CNXC.
Where does this CNXC ownership data come from?: SEC Form 13F-HR filings, accessed via EDGAR. 13F filings are disclosed quarterly with a 45-day reporting delay and cover U.S.-listed long equity positions only. This is not investment advice.